The Voyant advanced bipolar system collects information about the nature of the tissue within its jaws, rapidly and constantly measures tissue as the energy is applied, and adjusts to provide the optimal amount of energy throughout the seal cycle to create a permanent, fused seal.
By learning from live human tissue, the Voyant system has redefined advanced energy through continuous advancements resulting in superior hemostasis,* faster seal times,† minimal lateral thermal spread,‡ and less tissue adherence.†
* Unpublished test reports compared with the data of a leading advanced bipolar device. February and March 2021 benchtop testing using ex vivo porcine tissue.
† Based on an unpublished test report from April 2020, comparing the current algorithm to the previous algorithm. Benchtop testing was conducted using ex vivo porcine tissue.
‡ Based on unpublished H&E histological analysis performed in April 2020, comparing the current algorithm to the previous algorithm. Testing was conducted using in vivo porcine tissue.
§ Surgeon feedback collected from EB215, EB210, EB230 and EB240 cases in 2020 and 2021, comparing the current algorithm to the previous algorithm.
* Unpublished test reports compared with the data of a leading advanced bipolar device. February and March 2021 benchtop testing using ex vivo porcine tissue.
† Based on an unpublished test report from April 2020, comparing the current algorithm to the previous algorithm. Benchtop testing was conducted using ex vivo porcine tissue.
‡ Based on unpublished H&E histological analysis performed in April 2020, comparing the current algorithm to the previous algorithm. Testing was conducted using in vivo porcine tissue.
§ Surgeon feedback collected from EB215, EB210, EB230 and EB240 cases in 2020 and 2021, comparing the current algorithm to the previous algorithm.
